Table 3

Anti-HBc positivity in patients with hepatitis C virus (HCV) related chronic liver disease and control patients matched by age

Age (years)	Control	Anti-HCV positive chronic liver disease
20–29	5.4	9.1^3-150
30–39	10.8	27.2^3-150
40–49	11.8	41.5^3-151
50–59	12.6	43.6^3-151
⩾60	14.8	54.2^3-151

Values represent percentages of the total number of patients in each group. Anti-HBc, antibody to hepatitis B core antigen.
↵3-150 Significantly higher than control (p<0.05).
↵3-151 Significantly higher than control (p<0.01).